Feed Preview

Going Viral

Tau Aggregation: Genomics

Tau Aggregation: Genomics diagram by Designua, Shutterstock
Designua, Shutterstock

Tau Aggregation is an important characteristic in some neurodegenerative disorders, including Alzheimer’s Disease. Discover the latest research using genomics to understand Tau Aggregation.

Top 20 most recent papers
Neuropsychologia

Word retrieval across the biomarker-confirmed Alzheimer's disease syndromic spectrum

NeuropsychologiaFebruary 15, 2020
Deepti PutchaKathryn V Papp
Annals of Neurology

Sleep deprivation affects tau phosphorylation in human cerebrospinal fluid

Annals of NeurologyFebruary 15, 2020
Nicolas R BarthélemyBrendan P Lucey
28
bioRxiv

Protein-protein interactions in neurodegenerative diseases: a conspiracy theory.

bioRxivFebruary 11, 2020
Travis B ThompsonAlain Goriely
10
Biosensors & Bioelectronics

Femtomolar sensing of Alzheimer's tau proteins by water oxidation-coupled photoelectrochemical platform

Biosensors & BioelectronicsFebruary 15, 2020
Kayoung Kim, Chan Beum Park
Nature Reviews. Neurology

Imaging shows predictive power of tau pathology in Alzheimer disease

Nature Reviews. NeurologyFebruary 14, 2020
Ian Fyfe
5
International Journal of Molecular Sciences

Chronic Mild Stress Modified Epigenetic Mechanisms Leading to Accelerated Senescence and Impaired Cognitive Performance in Mice

International Journal of Molecular SciencesFebruary 14, 2020
Dolors Puigoriol-IllamolaMercè Pallàs
Neurobiology of Aging

CSF cutoffs for MCI due to AD depend on APOEε4 carrier status

Neurobiology of AgingFebruary 8, 2020
Moira MarizzoniGiovanni B Frisoni
2
1
Journal of Clinical Medicine

Curcumin's Nanomedicine Formulations for Therapeutic Application in Neurological Diseases

Journal of Clinical MedicineFebruary 9, 2020
Bahare SalehiJavad Sharifi-Rad
2
1
Journal of Child Psychology and Psychiatry, and Allied Disciplines

Deconstructing the repetitive behaviour phenotype in autism spectrum disorder through a large population-based analysis

Journal of Child Psychology and Psychiatry, and Allied DisciplinesFebruary 11, 2020
Mirko UljarevićAndrew J O Whitehouse
5
Acta Crystallographica. Section D, Structural Biology

Amyloid structure determination in RELION-3.1

Acta Crystallographica. Section D, Structural BiologyFebruary 11, 2020
Sjors H W Scheres
23
1
Cell Reports

Transcriptional Signatures of Tau and Amyloid Neuropathology

Cell ReportsFebruary 13, 2020
Isabel CastanhoJonathan Mill
50
5

See more papers from this feed

Related Feeds

ALS

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

ALS & FTD: TDP-43

ALS shares with a considerable proportion of FTD cases the same neuropathological substrate, namely, inclusions of abnormally phosphorylated protein tdp-43 (ptdp-43). Here are the latest discoveries pertaining to ptdp-43 and these diseases.

ALS - Pathogenic Mechanisms

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS - Phenotypes

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating phenotypes associated with this genetically heterogeneous disorder.

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here are the latest discoveries pertaining to this disease.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS therapies here.

ALS: Transposon de-silencing

Transposon silencing is a form of transcriptional gene silencing. These gene silencing mechanisms are impaired in Amyotrophic lateral sclerosis (ALS). Here are the latest discoveries pertaining to transposon silencing and this disease.

Age-related Dementia

Age-related dementia (Alzheimer's disease) results from the destructive impact of the pulse on cerebral vasculature. Evidence is reviewed that the neuropathology of the dementia is caused by the breakdown of small cerebral vessels (silent microbleeds), that the microbleeds result from pulse-induced damage to the cerebral vessels, and that pulse becomes increasingly destructive with age, because of the age-related stiffening of the aorta and great arteries, which causes an increase in the intensity of the pressure pulse. Discover the latest research on age-related dementia here.

© 2020 Meta ULC. All rights reserved
/feed-previews/tau-aggregation-genomics/dd022db5-6b6e-48b7-a623-82e481dc12ef